Product Information
BENAZEPRIL HCL 5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0484 per EA under NDC 62135071990. Its NADAC has been published 153 times since Nov 1, 2023.
FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135071990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076267FDA Approved
2/11/2004
TE Code
AB
On Market Since
8/20/2022
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 5 MG TABLET has been published 153 times since Nov 1, 2023, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0484 per EA |
|---|---|
| All-time high | $0.0604 (Jan 10, 2024) |
| All-time low | $0.0272 (Nov 20, 2024) |
| 52-week high | $0.0513 |
| 52-week low | $0.0459 |
| Median price | $0.0481 |
| Average price | $0.0467 |
| Largest weekly change | +58.6% (Jun 19, 2024) |
| Weeks tracked | 153 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Benazepril hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benazepril hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 5 MG TABLET, manufactured by Chartwell RX LLC, is $0.0484 per EA (NDC 62135071990), effective Sep 30, 2026.
How has the price of BENAZEPRIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 5 MG TABLET has declined 9.3%. It has been tracked across 153 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 5 MG TABLET?
Since Nov 1, 2023, the NADAC for BENAZEPRIL HCL 5 MG TABLET has ranged from a low of $0.0272 (Nov 20, 2024) to a high of $0.0604 (Jan 10, 2024), with a median of $0.0481 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BENAZEPRIL HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENAZEPRIL HCL 5 MG TABLET?
BENAZEPRIL HCL 5 MG TABLET (NDC 62135071990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.